Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-08-31 16:55:12 ET · period of report 2026-08-31 · accession 0001061983-26-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-31 16:55 | 2026-08-31 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $10.60 | +7,500 | 385.3K | +2% | +$79.5K |
| DT | 2026-08-31 16:55 | 2026-08-31 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $70.24 | -7,500 | 377.8K | -2% | -$526.8K |
| DT | 2026-08-31 16:55 | 2026-08-31 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $0.00 | -7,500 | 164.2K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-31 | M | A | 7,500 | $10.60 | 385,320 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-31 | S | D | 7,500 | $70.24 | 377,820 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-08-31 | M | D | 7,500 | $0.00 | 164,245 | D | $10.60 · 2017-03-28 to 2027-02-28 | 7,500 Common Stock |